Population Pharmacokinetics of Tenofovir in Pregnant and Postpartum Women Using Tenofovir Disoproxil Fumarate.

导出 OA

翻译打印收藏纠错

作者： Ahizechukwu C,Eke ^[1] ; Kensuke,Shoji ^[2] ; Brookie M,Best ^[3] ; Jeremiah D,Momper ^[4] ; Alice M,Stek ^[5] ; Tim R,Cressey ^[6] ; Mark,Mirochnick ^[7] ; Edmund V,Capparelli ^[3]

作者单位： Division of Maternal Fetal Medicine, Department of Gynecology & Obstetrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA aeke2@jhu.edu.;Doctoral Training Program (PhD), Graduate Training Program in Clinical Investigation (GTPCI), Johns Hopkins University School of Public Health, Baltimore, Maryland, USA. ^[1] Division of Infectious Diseases, Department of Medical Subspecialties, National Center for Child Health and Development, Tokyo, Japan. ^[2] University of California San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences, La Jolla, California, USA.;Pediatrics Department, University of California San Diego-Rady Children's Hospital San Diego, San Diego, California, USA. ^[3] University of California San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences, La Jolla, California, USA. ^[4] Division of Maternal Fetal Medicine, Department of Obstetrics & Gynecology, University of Southern California School of Medicine, Los Angeles, California, USA. ^[5] PHPT/IRD UMI 174, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand.;Department of Molecular & Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom. ^[6] Division of Neonatology, Department of Pediatrics, Boston University School of Medicine, Boston, Massachusetts, USA. ^[7]

关键词 AIDS HIV TDF population pharmacokinetics postpartum pregnancy tenofovir tenofovir disoproxil fumarate

主题词抗HIV药(Anti-HIV Agents);女(雌)性(Female);HIV感染(HIV Infections);HIV-1(HIV-1);人类(Humans);产后期(Postpartum Period);妊娠(Pregnancy)

DOI 10.1128/AAC.02168-20

PMID 33318014

发布时间 2024-09-10

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交